IL‐31 and IL‐31 receptor alpha in pemphigus: Contributors to more than just itch?

The pruritogenic role of the type 2 immune response in diseases associated with chronic itch

(2021) Giuseppe Ingrasci et al.   EXPERIMENTAL DERMATOLOGY

Comprehensive review on the pathophysiology, clinical variants and management of pemphigus (Review)

(2021) Victor-Vlad Costan et al.   Experimental and Therapeutic Medicine

Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis

(2020) Sonja Ständer et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Cytokine TGF-β Induces Interleukin-31 Expression from Dermal Dendritic Cells to Activate Sensory Neurons and Stimulate Wound Itching

(2020) Junji Xu et al.   IMMUNITY

Increased expression of in situ IL‐31RA and circulating CXCL8 and CCL2 in pemphigus herpetiformis suggests participation of the IL‐31 family in the pathogenesis of the disease

(2020) K.L. Morais et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus

(2020) Kenji Kabashima et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pruritus in Autoimmune and Inflammatory Dermatoses

(2019) Claudia Zeidler et al.   Frontiers in Immunology

Mechanisms of Itch in Stasis Dermatitis: Significant Role of IL-31 from Macrophages

(2019) Takashi Hashimoto et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Possible Roles of Basophils in Chronic Itch

(2018) Takashi Hashimoto et al.   EXPERIMENTAL DERMATOLOGY

Itch: From mechanism to (novel) therapeutic approaches

(2018) Gil Yosipovitch et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

IL-31-Driven Skin Remodeling Involves Epidermal Cell Proliferation and Thickening That Lead to Impaired Skin-Barrier Function

(2016) Brijendra Singh et al.   PLoS One

IL-31 Is Overexpressed in Lichen Planus but Its Level Does Not Correlate with Pruritus Severity

(2015) Kalina Welz-Kubiak et al.   Journal of Immunology Research